|
GB209551A
(en)
|
1922-11-20 |
1924-01-17 |
William Mortimer Melmore |
Improvements in or relating to petrol and other cans
|
|
JPS54130587A
(en)
*
|
1978-03-30 |
1979-10-09 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
|
CA1209477A
(en)
|
1981-03-26 |
1986-08-12 |
Bruce E. Haeger |
Composition of matter comprising a lyophilized preparation of a penicillin derivative
|
|
JPS5832899A
(ja)
|
1981-08-18 |
1983-02-25 |
Takeda Chem Ind Ltd |
オキセンドロン水性懸濁剤
|
|
US4352811A
(en)
*
|
1981-11-12 |
1982-10-05 |
Hoechst-Roussel Pharmaceuticals Inc. |
3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
|
|
IL68549A
(en)
*
|
1983-05-03 |
1988-05-31 |
Kit Medidont Ltd |
Method and instrument for measuring moisture
|
|
KR850004274A
(ko)
*
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
US4804663A
(en)
*
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
US5006528A
(en)
*
|
1988-10-31 |
1991-04-09 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
JP2608788B2
(ja)
|
1988-10-31 |
1997-05-14 |
大塚製薬 株式会社 |
精神分裂病治療剤
|
|
FR2663223B1
(fr)
|
1990-06-14 |
1994-12-02 |
Af Aplicaciones Far Lab |
Forme galenique parenterale.
|
|
JP3282731B2
(ja)
*
|
1990-06-15 |
2002-05-20 |
メルク エンド カムパニー インコーポレーテッド |
結晶の構造および大きさを改良する結晶化方法
|
|
IT1244880B
(it)
|
1990-12-11 |
1994-09-12 |
Torre A Farmaceutici |
Formulazioni di amminoacidi liofilizzati contenenti glutammina, loro preparazione ed uso nell'alimentazione parenterale
|
|
US6193983B1
(en)
*
|
1992-06-01 |
2001-02-27 |
The University Of Melbourne |
Equine herpesvirus glycoproteins
|
|
TW376319B
(en)
*
|
1993-04-28 |
1999-12-11 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
|
|
SK282231B6
(sk)
*
|
1993-11-19 |
2001-12-03 |
Janssen Pharmaceutica N. V. |
Farmaceutický prostriedok na liečenie psychotických porúch
|
|
ES2194911T3
(es)
|
1994-06-02 |
2003-12-01 |
Elan Drug Delivery Ltd |
Metodo para evitar la agregacion de proteinas/peptidos cuando tiene lugar su rehidratacion o descongelacion.
|
|
RU2082401C1
(ru)
|
1994-08-18 |
1997-06-27 |
Фармацевтическое акционерное общество "Ферейн" |
Способ получения лекарственной формы комбинированного препарата
|
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US6165442A
(en)
*
|
1996-02-19 |
2000-12-26 |
Nycomed Imaging As |
Thermally stabilized ultrasound contrast agent
|
|
DE69725877T2
(de)
|
1996-08-26 |
2004-07-22 |
Transgene S.A. |
Kationische lipid-nukleinsäure komplexe
|
|
US6297231B1
(en)
*
|
1996-10-28 |
2001-10-02 |
Merck & Co., Inc. |
Stabilized carbapenem antibiotic compositions and method of making
|
|
GB9705588D0
(en)
*
|
1997-03-18 |
1997-05-07 |
Anglia Research Foundation |
Stable particle in liquid formulations
|
|
GB9718986D0
(en)
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
|
CA2326456C
(en)
|
1998-03-30 |
2008-12-23 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
|
DE69935433T2
(de)
*
|
1998-07-30 |
2007-10-25 |
Point Biomedical Corp., San Carlos |
Neuer wirkstoffträger für die gefriertrocknung von wässrigen suspensionen von mikropartikeln
|
|
DE19857609A1
(de)
*
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
|
US6455526B1
(en)
*
|
1998-12-16 |
2002-09-24 |
Aventis Pharmaceuticals, Inc. |
Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
|
|
US6267989B1
(en)
*
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
|
EP1814532B1
(en)
*
|
1999-05-27 |
2012-01-18 |
George F. El Khoury |
Topical application of muscarinic and opioid agents for treatment of tinnitus
|
|
JP2001187735A
(ja)
|
2000-01-05 |
2001-07-10 |
Towa Yakuhin Kk |
安定なニコランジル含有粉末の製造法
|
|
US6559128B1
(en)
*
|
2000-01-21 |
2003-05-06 |
Northwestern University |
Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
|
|
RU2169574C1
(ru)
|
2000-01-27 |
2001-06-27 |
Кобатов Алексей Иванович |
Способ получения биопрепарата и сухой биопрепарат
|
|
AU2001233180A1
(en)
|
2000-02-10 |
2001-08-20 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing a sustained release composition
|
|
CN1245967C
(zh)
|
2000-03-27 |
2006-03-22 |
斯克里普斯研究学院 |
化合物的制药用途
|
|
CN1313080C
(zh)
|
2000-04-20 |
2007-05-02 |
斯凯伊药品加拿大公司 |
改进的水不溶性药物粒子的制备方法
|
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
JP2002241284A
(ja)
|
2001-02-16 |
2002-08-28 |
Towa Yakuhin Kk |
全身投与用アルガトロバン注射液
|
|
MY129350A
(en)
|
2001-04-25 |
2007-03-30 |
Bristol Myers Squibb Co |
Aripiprazole oral solution
|
|
JP2003063965A
(ja)
*
|
2001-06-13 |
2003-03-05 |
Otsuka Pharmaceut Factory Inc |
注射用シロスタゾール水性製剤
|
|
MXPA03011538A
(es)
|
2001-06-14 |
2004-03-09 |
Otsuka Pharma Co Ltd |
Composicion medicinal que sustancialmente no causaria dano a la mucosa intestinal.
|
|
DE60224293T2
(de)
|
2001-09-21 |
2008-12-11 |
Egalet A/S |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
|
AR033485A1
(es)
|
2001-09-25 |
2003-12-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
|
ITMI20020808A1
(it)
*
|
2002-04-17 |
2003-10-17 |
Chiesi Farma Spa |
Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
|
|
GB0216416D0
(en)
|
2002-07-15 |
2002-08-21 |
Novartis Ag |
Organic compounds
|
|
JP4776229B2
(ja)
*
|
2002-07-16 |
2011-09-21 |
エラン ファーマ インターナショナル，リミティド |
安定なナノ粒子活性物質の液体投与組成物
|
|
HRP20050149B1
(hr)
*
|
2002-08-20 |
2014-09-12 |
Otsuka Pharmaceutical Co., Ltd. |
Formulacija aripiprazol kompleksa i postupak
|
|
ITMI20022674A1
(it)
|
2002-12-18 |
2004-06-19 |
Chiesi Farma Spa |
Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
|
|
MXPA05007158A
(es)
*
|
2002-12-31 |
2005-09-21 |
Nektar Therapeutics |
Formulacion farmaceutica con un agente activo insoluble.
|
|
WO2004064752A2
(en)
|
2003-01-22 |
2004-08-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
|
JP2005022989A
(ja)
|
2003-06-30 |
2005-01-27 |
Otsuka Pharmaceut Factory Inc |
可溶化または分散化された難溶性化合物を含む組成物
|
|
US6987111B2
(en)
*
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
|
US20050032811A1
(en)
|
2003-08-06 |
2005-02-10 |
Josiah Brown |
Methods for administering aripiprazole
|
|
TWI371274B
(en)
|
2003-10-23 |
2012-09-01 |
Bristol Myers Squibb Co |
Process for making sterile aripiprazole of desired mean particle size
|
|
JP4836797B2
(ja)
*
|
2003-10-23 |
2011-12-14 |
大塚製薬株式会社 |
放出制御性無菌注射アリピプラゾール製剤および方法
|
|
CA2543296A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Point Biomedical Corporation |
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
|
WO2005072702A2
(en)
*
|
2004-01-20 |
2005-08-11 |
Alkermes Controlled Therapeutics, Inc. |
Method for milling frozen microparticles
|
|
WO2005089718A2
(en)
*
|
2004-03-23 |
2005-09-29 |
Novartis Ag |
Pharmaceutical compositions
|
|
DE102005011786A1
(de)
*
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
WO2006097343A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Synthon B.V. |
Process of making crystalline type ii aripiprazole
|
|
CA2622758A1
(en)
|
2005-09-15 |
2007-03-29 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
|
US9034381B2
(en)
*
|
2005-11-10 |
2015-05-19 |
Alphapharm Pty Ltd |
Process to control particle size
|
|
US20070148245A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Ilan Zalit |
Compressed solid dosage forms with drugs of low solubility and process for making the same
|
|
MX2010001311A
(es)
*
|
2007-07-31 |
2010-04-21 |
Otsuka Pharma Co Ltd |
Metodo para producir una suspensi?n de aripiprazol y formulacion liofilizada.
|